Arjun Agarwal, Senior Vice President, Finance at Oruka Therapeutics, Inc. (ORKA), sold 1,587 shares at $80.01 ($128K) on 2026-06-22, disclosed to the SEC on 2026-06-22.
Scheduled sale ($128k) by Senior Vice President, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.01 | 888 | $71K | 55.3% |
| 2 | $82.14 | 699 | $57K | 44.7% |
| Total | $80.95 avg | 1,587 | $128K | 100% |
| Filing → |
| ORKA | SELL | 2026-09-15 | $926K | — | Filing → |
| ORKA | SELL | 2026-08-14 | $1.1M | — | Filing → |
| ORKA | SELL | 2026-07-13 | $846K | — | Filing → |